Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 530,180 | 347,487 | 605,378 | 594,612 | 604,363 |
| Marketable Securities | 416,602 | 304,606 | 172,266 | 139,794 | 171,349 |
| Receivables | 263,865 | 240,584 | 203,623 | 199,403 | 178,317 |
| Inventories | 127,373 | 128,534 | 127,475 | 132,841 | 130,770 |
| TOTAL | $1,452,487 | $1,120,270 | $1,194,369 | $1,148,186 | $1,173,928 |
| Non-Current Assets | |||||
| PPE Net | 703,083 | 702,041 | 698,354 | 692,404 | 686,602 |
| Intangibles | 4,210,450 | 4,233,908 | 4,257,516 | 4,279,821 | 4,256,807 |
| Other Non-Current Assets | 307,275 | 320,102 | 321,095 | 300,419 | 238,226 |
| TOTAL | $5,220,808 | $5,256,051 | $5,276,965 | $5,272,644 | $5,181,635 |
| Total Assets | $6,673,295 | $6,376,321 | $6,471,334 | $6,420,830 | $6,355,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 248,923 | 298,810 | 50,000 | 50,000 | 50,000 |
| Accounts payable and accrued liabilities | 52,980 | 60,498 | 78,816 | 73,558 | 75,080 |
| Accrued Expenses | 302,540 | 265,121 | 341,683 | 309,872 | 299,586 |
| Other current liabilities | 37,103 | 33,455 | 14,823 | 12,694 | 33,519 |
| TOTAL | $668,642 | $685,109 | $514,701 | $476,513 | $488,057 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,812,291 | 2,558,594 | 2,811,328 | 2,823,090 | 2,810,884 |
| TOTAL | $2,812,291 | $2,558,594 | $2,811,328 | $2,823,090 | $2,810,884 |
| Total Liabilities | $3,480,933 | $3,243,703 | $3,326,029 | $3,299,603 | $3,298,941 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 184,770 | 184,530 | 181,531 | 180,850 | 180,665 |
| Common Shares | 1,848 | 1,839 | 1,815 | 1,809 | 1,806 |
| Retained earnings | -3,595,211 | -3,579,403 | -3,469,175 | -3,419,409 | -3,420,203 |
| Other shareholders' equity | -943 | -499 | 1,428 | -1,535 | -723 |
| TOTAL | $3,192,362 | $3,132,618 | $3,145,305 | $3,121,227 | $3,056,622 |
| Total Liabilities And Equity | $6,673,295 | $6,376,321 | $6,471,334 | $6,420,830 | $6,355,563 |